Hikal Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hikal Ltd with three other
companies in this sector in India:
Marksans Pharma Limited
sales of 8.93 billion Indian Rupees [US$136.50 million]
of which 100%
was Bulk Drugs Division),
(9.96 billion Indian Rupees [US$152.24 million]
Orchid Pharma Ltd
(8.73 billion Indian Rupees [US$133.46 million]
Hikal Ltd reported sales of 9.26 billion Indian Rupees (US$141.44 million)
March of 2016.
increase of 6.2%
versus 2015, when the company's sales were 8.72 billion Indian Rupees.
This was the third consecutive year of growth at Hikal Ltd.
Sales of Corp Protection Products saw an increase
6.6% in 2016, from
3.34 billion Indian Rupees to 3.57 billion Indian Rupees.